Eloxx Pharmaceuticals annual operating margin
2010
2012
2013
2014
Eloxx Pharmaceuticals's operating margin was −5,019.95% for fiscal 2014.
View full Eloxx Pharmaceuticals company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2014 | 2014-06-30 | −5,019.95% | +54456.97 pp |
| 2013 | 2013-06-30 | −59,476.92% | −56771.15 pp |
| 2012 | 2012-06-30 | −2,705.76% | +756.04 pp |
| 2010 | 2010-06-30 | −3,461.80% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2012 | 2011-12-31 | −728.07% | — |
Across the available reported history, Eloxx Pharmaceuticals's operating margin increased from −59,476.92% to −5,019.95%, a change of +54456.97 percentage points. The latest reported quarter, Q2 2012, shows −728.07%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Eloxx Pharmaceuticals filings at SEC.gov ↗